COVID-19 Vaccine Updates COVID-19 Vaccine Updates: Vaccine Safety
Nov 3, 2021
Kevin Winthrop, a Professor of Infectious Diseases and Epidemiology at Oregon Health and Science University, dives deep into the safety profiles of mRNA and adenoviral COVID-19 vaccines. He discusses their efficacy, addressing rare side effects and the crucial benefit-risk ratios. Winthrop emphasizes the importance of vaccination in minimizing severe cases, especially during peaks of the pandemic. His insights provide valuable information for anyone concerned about vaccine safety.
AI Snips
Chapters
Transcript
Episode notes
mRNA Vaccines' Exceptional Benefit-Risk
- mRNA COVID-19 vaccines likely rank among the safest vaccines ever given widespread use and monitoring.
- Kevin Winthrop emphasizes the benefit-risk ratio strongly favors vaccination during the pandemic.
Expect Short-Lived Reactogenicity
- Reactogenicity (fatigue, myalgias, joint pain) is the most common vaccine side effect and is usually short-lived.
- These reactions are more common after the second dose and in younger people, and are not a sign to avoid vaccination.
Autoimmune Flares Are Rare And Manageable
- Early data do not show widespread flares of autoimmune disease after vaccination, with flare rates similar to baseline.
- Most flares that occur are manageable and not a reason to avoid vaccination for autoimmune patients.